First Eagle Investment Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,039,009
Closed -$1.87M 413
2024
Q2
$1.87M Buy
1,039,009
+260,000
+33% +$750K ﹤0.01% 324
2024
Q1
$3.71M Buy
779,009
+3,000
+0.4% +$10.5K 0.01% 293
2023
Q4
$2.25M Hold
776,009
0.01% 322
2023
Q3
$1.05M Buy
776,009
+195,834
+34% +$343K ﹤0.01% 339
2023
Q2
$1.25M Buy
580,175
+61,786
+12% +$150K ﹤0.01% 322
2023
Q1
$1.51M Buy
518,389
+150,496
+41% +$759K ﹤0.01% 308
2022
Q4
$2.53M Buy
367,893
+21,101
+6% +$99.6K 0.01% 229
2022
Q3
$1.1M Buy
346,792
+23,000
+7% +$83.6K ﹤0.01% 301
2022
Q2
$1.04M Sell
323,792
-15,676
-5% -$45.5K ﹤0.01% 288
2022
Q1
$1.03M Buy
339,468
+119,585
+54% +$404K ﹤0.01% 283
2021
Q4
$981K Buy
219,883
+162,514
+283% +$796K ﹤0.01% 175
2021
Q3
$376K Buy
57,369
+54,030
+1,618% +$518K ﹤0.01% 166
2021
Q2
$53K Buy
+3,339
New +$46.1K ﹤0.01% 187

Other funds holding STIM

First Eagle Investment Management's STIM Position: Q3 2024 in Review

First Eagle Investment Management sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 1,039,009 shares — an estimated $1.87M sold.

First Eagle Investment Management first reported a position in STIM in Q2 2021 and held it in 13 quarters. The position peaked at $3.71M in Q1 2024. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

  • First Eagle Investment Management reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
  • First Eagle Investment Management sold 1,039,009 Neuronetics shares in Q3 2024, an estimated $1.87M.
  • First Eagle Investment Management first reported a position in Neuronetics in Q2 2021 and held it in 13 quarters.
  • First Eagle Investment Management's Neuronetics position peaked at $3.71M in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on First Eagle Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.